Analysts Set KORU Medical Systems, Inc. (NASDAQ:KRMD) PT at $4.63

Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $4.6250.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of KORU Medical Systems in a research report on Wednesday, October 8th.

Institutional Investors Weigh In On KORU Medical Systems

Several hedge funds have recently bought and sold shares of the stock. Lazard Asset Management LLC purchased a new stake in KORU Medical Systems in the 2nd quarter worth approximately $59,000. First Light Asset Management LLC boosted its position in KORU Medical Systems by 5.1% in the 2nd quarter. First Light Asset Management LLC now owns 4,681,626 shares of the company’s stock worth $16,760,000 after purchasing an additional 226,700 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in KORU Medical Systems in the 2nd quarter worth approximately $83,000. Archon Capital Management LLC boosted its position in KORU Medical Systems by 23.5% in the 2nd quarter. Archon Capital Management LLC now owns 700,147 shares of the company’s stock worth $2,507,000 after purchasing an additional 133,277 shares in the last quarter. Finally, Invesco Ltd. purchased a new stake in KORU Medical Systems in the 2nd quarter worth approximately $80,000. Hedge funds and other institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Price Performance

Shares of NASDAQ KRMD opened at $3.90 on Tuesday. The business’s 50 day moving average price is $4.07 and its 200 day moving average price is $3.51. The firm has a market cap of $180.34 million, a P/E ratio of -43.33 and a beta of 0.49. KORU Medical Systems has a 52 week low of $1.86 and a 52 week high of $5.05. The company has a quick ratio of 2.25, a current ratio of 2.91 and a debt-to-equity ratio of 0.01.

KORU Medical Systems (NASDAQ:KRMD) last issued its earnings results on Wednesday, August 6th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.04. KORU Medical Systems had a negative return on equity of 26.77% and a negative net margin of 12.24%.The firm had revenue of $10.20 million for the quarter, compared to analyst estimates of $9.46 million. On average, sell-side analysts expect that KORU Medical Systems will post -0.13 earnings per share for the current year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.